ALEXANDRIA, Va., April 2 -- United States Patent no. 12,264,152, issued on April 1, was assigned to Algen Biotechnologies Inc. (San Francisco).
"Certain chemical compositions and methods of use thereof" was invented by Andrei W. Konradi (Burlingame, Calif.), Chun-Hao Huang (San Francisco) and Ko-Chuan Lee (San Francisco).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides CDK9 inhibitors. Also provided are methods of treating a disease or a disorder comprising administering to a subject in need of treatment one of the CDK9 inhibitors disclosed herein. In some embodiments, the disease or disorder to be treated is cancer. In some embodiments, the disease or disorder is liver cancer."...